107 related articles for article (PubMed ID: 12894545)
1. Overexpression of a novel lysyl oxidase-like gene in human head and neck squamous cell carcinomas.
Holtmeier C; Görögh T; Beier U; Meyer J; Hoffmann M; Gottschlich S; Heidorn K; Ambrosch P; Maune S
Anticancer Res; 2003; 23(3B):2585-91. PubMed ID: 12894545
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of p68 mRNA in head and neck squamous cell carcinoma cells.
Beier UH; Maune S; Meyer JE; Görögh T
Anticancer Res; 2006; 26(3A):1941-6. PubMed ID: 16827128
[TBL] [Abstract][Full Text] [Related]
3. Selective upregulation and amplification of the lysyl oxidase like-4 (LOXL4) gene in head and neck squamous cell carcinoma.
Görögh T; Weise JB; Holtmeier C; Rudolph P; Hedderich J; Gottschlich S; Hoffmann M; Ambrosch P; Csiszar K
J Pathol; 2007 May; 212(1):74-82. PubMed ID: 17354256
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Pim-1 in head and neck squamous cell carcinomas.
Beier UH; Weise JB; Laudien M; Sauerwein H; Görögh T
Int J Oncol; 2007 Jun; 30(6):1381-7. PubMed ID: 17487358
[TBL] [Abstract][Full Text] [Related]
5. Reduction of LOX- and LOXL2-mRNA expression in head and neck squamous cell carcinomas.
Rost T; Pyritz V; Rathcke IO; Görögh T; Dünne AA; Werner JA
Anticancer Res; 2003; 23(2B):1565-73. PubMed ID: 12820424
[TBL] [Abstract][Full Text] [Related]
6. LOXL4 as a selective molecular marker in primary and metastatic head/neck carcinoma.
Scola N; Görögh T
Anticancer Res; 2010 Nov; 30(11):4567-71. PubMed ID: 21115907
[TBL] [Abstract][Full Text] [Related]
7. [Re-amplification of differentially expressed mRNA fragments of head-neck cancers without cloning].
Weber EH; Gottschlich S; Lippert BM; Görögh T; Folz BJ; Eggers S; Werner JA
Laryngorhinootologie; 1998 Jan; 77(1):43-7. PubMed ID: 9522312
[TBL] [Abstract][Full Text] [Related]
8. Differentially expressed genes in head and neck cancer.
Gottschlich S; Folz BJ; Lippert BM; Niemann AM; Goeroegh T; Werner JA
Laryngoscope; 1998 May; 108(5):639-44. PubMed ID: 9591538
[TBL] [Abstract][Full Text] [Related]
9. [Detection of differentially expressed genes in head-neck carcinomas].
Werner JA; Gottschlich S; Görögh T; Folz BJ; Lippert BM; Niemann AM
Laryngorhinootologie; 1997 May; 76(5):300-7. PubMed ID: 9280417
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number.
Canel M; Secades P; Rodrigo JP; Cabanillas R; Herrero A; Suarez C; Chiara MD
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3272-9. PubMed ID: 16740747
[TBL] [Abstract][Full Text] [Related]
11. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
[TBL] [Abstract][Full Text] [Related]
12. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the human myosin-binding protein-C1 mRNA in laryngeal squamous cell carcinoma cells.
Beier UH; Görögh T; Holtmeier C; Ambrosch P; Maune S
Anticancer Res; 2002; 22(6A):3343-7. PubMed ID: 12530085
[TBL] [Abstract][Full Text] [Related]
14. S19-mRNA expression in squamous cell carcinomas of the upper aerodigestive tract.
Sengpiel V; Rost T; Görögh T; Rathcke IO; Werner JA
Anticancer Res; 2004; 24(4):2161-7. PubMed ID: 15330156
[TBL] [Abstract][Full Text] [Related]
15. Novel integrative methods for gene discovery associated with head and neck squamous cell carcinoma development.
Smith IM; Mithani SK; Liu C; Chang SS; Begum S; Dhara M; Westra W; Sidranksy D; Califano JA
Arch Otolaryngol Head Neck Surg; 2009 May; 135(5):487-95. PubMed ID: 19451471
[TBL] [Abstract][Full Text] [Related]
16. Identification of molecular targets in head and neck squamous cell carcinomas based on genome-wide gene expression profiling.
Shimizu S; Seki N; Sugimoto T; Horiguchi S; Tanzawa H; Hanazawa T; Okamoto Y
Oncol Rep; 2007 Dec; 18(6):1489-97. PubMed ID: 17982635
[TBL] [Abstract][Full Text] [Related]
17. Head and neck squamous cell carcinoma transcriptome analysis by comprehensive validated differential display.
Carles A; Millon R; Cromer A; Ganguli G; Lemaire F; Young J; Wasylyk C; Muller D; Schultz I; Rabouel Y; Dembélé D; Zhao C; Marchal P; Ducray C; Bracco L; Abecassis J; Poch O; Wasylyk B
Oncogene; 2006 Mar; 25(12):1821-31. PubMed ID: 16261155
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.
Chung CH; Parker JS; Ely K; Carter J; Yi Y; Murphy BA; Ang KK; El-Naggar AK; Zanation AM; Cmelak AJ; Levy S; Slebos RJ; Yarbrough WG
Cancer Res; 2006 Aug; 66(16):8210-8. PubMed ID: 16912200
[TBL] [Abstract][Full Text] [Related]
19. Vaccination strategy to target lysyl oxidase-like 4 in dendritic cell based immunotherapy for head and neck cancer.
Weise JB; Csiszar K; Gottschlich S; Hoffmann M; Schmidt A; Weingartz U; Adamzik I; Heiser A; Kabelitz D; Ambrosch P; Görögh T
Int J Oncol; 2008 Feb; 32(2):317-22. PubMed ID: 18202753
[TBL] [Abstract][Full Text] [Related]
20. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
